clinical trial · NCT06868082
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants
Uniquity One (UNI)·phase1·completed·n = 32
HealthySolrikitugSolrikitug
brief summary
A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and non-Japanese Participants
started
Jun 20, 2025
primary completion
Feb 2, 2026
completion
Feb 2, 2026
last updated
Feb 9, 2026
official title
A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and Non-Japanese Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol